An Italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
Partnering
MediaPharma intends to advance its proprietary products portfolio to initial clinical safety and efficacy endpoints, then form strategic partnerships with companies that have the necessary commercialization infrastructures to best capture value.
However, we are interested in forging partnership alliances at all development stages should such arrangements facilitate the rapid development of the product.
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
